MK-801 inhibits l-DOPA-induced abnormal involuntary movements only at doses that worsen parkinsonism

Melanie A. Paquette, Akari M. Anderson, Jason R. Lewis, Charles K. Meshul, Steven W. Johnson, S. Paul Berger

Research output: Contribution to journalArticle

24 Scopus citations

Fingerprint Dive into the research topics of 'MK-801 inhibits l-DOPA-induced abnormal involuntary movements only at doses that worsen parkinsonism'. Together they form a unique fingerprint.

Medicine & Life Sciences